Skip to content

Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.

All Clinical Trials

Researchers with the ACADIA Study are trying to determine if a rescue inhaler that doctors can currently prescribe for adults can also help adolescents control their asthma flare-ups. Volunteers are needed. Learn if you are eligible:

Chronic insomnia is a serious health concern that affects around 10% of people in America. Current treatments are varied, and often target things that may result in sleep disruption. In this study, researchers are evaluating two common treatments for insomnia in adults to learn more about how they treat symptoms.

Postural Orthostatic Tachycardia Syndrome, or POTS, is a chronic condition that involves sudden, rapid increases in heart rate when sitting or standing. This condition can disrupt daily life and trigger other symptoms such as fatigue, dizziness or vertigo. Research has linked POTS symptoms to long-haul COVID-19 infections, but the connection between these conditions is still being studied.

Progressive Pulmonary Fibrosis (PPF) is a rare lung disease that causes scarring in the lung. Researchers are investigating if an inhaled study treatment can help improve lung function with fewer side effects than current treatments.

Food allergies are complex, and researchers are studying new ways to predict who might develop allergies in the future. In this study, researchers are trying to determine if skin reactions during an oral food challenge can predict food allergies. They also are evaluating if a biologic called omalizumab, which is currently approved to treat asthma, can help people with food allergies.

Pulmonary hypertension (PH), or high blood pressure in the lungs, can often develop in those who have interstitial lung disease (ILD). Treatments for this combination of diseases, called PH-ILD, to try and improve quality of life for people with both conditions are currently being evaluated.

Many people with eczema (also known as atopic dermatitis) have dry skin, in addition to their other symptoms, which can worsen itching, scratching and skin pain. Researchers want to know if dupilumab, a current immune system treatment for eczema, also may be able to have a long-term impact on dry skin in children with eczema.

In severe asthma, some of the exacerbations that cause difficulty breathing are the result of inflammation in the lung. Researchers are testing a class of anti-inflammatory drugs called a JAK1 inhibitor that has worked to treat other inflammatory conditions like eczema to see if it can help people with severe asthma.

Some people with asthma experience frequent exacerbations, involving swelling or narrowing of the airways, which causes shortness of breath, wheezing and cough. In the national study called VALIANT, researchers are evaluating a new investigational treatment called verekitug to see if it is safe and can effectively reduce inflammation to help asthma patients breathe easier.

Pulmonary hypertension and pulmonary arterial hypertension are two conditions that can cause increased blood pressure within the lungs. The differences between the two conditions on a cellular level are not well understood, and researchers are evaluating cell samples from people that are undergoing a right heart catheterization to learn more about these two diseases and improve future care.

People with cystic fibrosis (CF) are more vulnerable to a wide variety of bacterial infections in their lungs. One of these bacteria, Pseudomonas aeruginosa, can cause infections that decrease lung function over time. Researchers are evaluating a new therapy that may help people with CF more effectively clear these infections.

Aerify3

Treatments for chronic obstructive pulmonary disease (COPD) may still leave people experiencing wheezing, coughing, or shortness of breath. Researchers in the Aerify3 study are investigating a medication called itepekimab, which has shown some potential in earlier clinical trials to improve symptoms in those with COPD.

People with pulmonary sarcoidosis usually rely on corticosteroids to help manage symptoms. Researchers are investigating the safety of a new study drug called XTMAB-16 to see if it can help reduce corticosteroid use while treating the disease.

Keto-friendly salad

The keto diet has helped many people lose weight and improve their overall health. Researchers are investigating if it can also benefit people with a specific type of heart failure.

Patient smiling attached to monitor

Researchers in the ABATE Study are testing the safety of a drug called gallium nitrate for people with cystic fibrosis (CF) who also have been diagnosed with nontuberculous mycobacteria (NTM).

physician consulting military veteran

Many people returning from military deployment have developed asthma as a result of inhaling hazardous materials. Exposures to diesel, burn pits, biomass smoke and sandstorms during deployment likely play a role. Some people with deployment-related asthma do not respond well to standard asthma medications.

cystic fibrosis label

For many people living with cystic fibrosis, there are treatments available called cystic fibrosis transmembrane conductance regulator (CFTR) modulators that can help treat the underlying cause of cystic fibrosis. However, more than 5,000 people living with cystic fibrosis have a change in both of their CFTR genes that makes them not expected to benefit from CFTR modulators.

physicians reviewing imaging

Determine the efficacy and safety of lurbinectedin (a type of chemotherapy) when combined with atezolizumab (an immunotherapy treatment) as a maintenance treatment for those with ES-SCLC.

physician taking patient vitals

Researchers are studying a new medication called PRA023 that has anti-inflammatory and antifibrotic properties to determine how well it works against systemic sclerosis (SSc) with interstitial lung disease (ILD).

adrenal glands

To help better understand adrenal insufficiency (AI) and its progression, researchers have developed a new registry called MyAI.

Current or Former smoker blood test can be used to identify cancers in adults.

Researchers want to learn if a blood test can be used to identify cancers in adults. Current or former smokers who have been diagnosed with cancer but haven’t started treatment are needed for this trial. Participants will receive a blood draw and review of their medical history with a research coordinator.

People with eosinophilic granulomatosis with polyangiitis (EGPA)

People with eosinophilic granulomatosis with polyangiitis (EGPA) are needed for the OCEAN clinical trial. The study compares two medications: mepolizumab (NUCALA), which is administered by an injection once a month, and depemokimab, an investigational medication that is injected twice a year.

Cystic Fibrosis, gene therapy, modulator therapy, CF Research

Adults with Cystic Fibrosis who are unable to take CFTR modulators are being asked to participate in a clinical trial for an investigational gene therapy drug known as 4D-710.

Lung health, healthy, young adult

Researchers are asking healthy adults, 25-35 years old, to join a five-year study exploring factors that may affect lung health with the goal of understanding lung disease.

preventing allergies in infants

Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.

woman smiling and looking to the future

Researchers are working to understand the different ways sarcoidosis, a disease that causes scarring in the lungs, develops.

teenager covering a cough

Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.

Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.

happy senior couple

Adults with cancer who are receiving immunotherapy are needed for a new research study to understand how immunotherapy changes the body’s immune response leading to skin reactions.

elderly man taking medication

Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.

mom with newborn

Researchers want to know what causes food allergies, eczema and wheezing in infants. If you’re pregnant, you may be able to help find the answer.

Patients with medically inoperable stage I/IIA non-small cell lung cancer (NSCLC) who have not received prior anticancer therapy for lung cancer, may qualify for a clinical trial investigating if the combination of pembrolizumab (MK-3475) and Stereotactic Body Radiation Therapy (SBRT) may help stop or slow a relapse of NSCLC compared to SBRT alone.

cutting concrete

If you’ve been exposed to silica dust, like stone and concrete, you may have developed a silica-related disease. National Jewish Health is creating a registry for silicosis and related diseases in order to better understand their risk factors and prevention.

predicting ILD from hypersensitivity pneumonitis

Anyone with hypersensitivity pneumonitis may qualify for this observational study and help researchers find patterns for predicting ILD.

applying oitment to hand

National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.

group of adults having a fun time

Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.

lung image

By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.

a couple hiking

By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.

parents posing with military son

The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.

couple in the forest

Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.

Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.

having food at a restaurant

The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).

woman smiling

If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.

lab researcher looking at specimen

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.

group of people smiling

Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.

Blood test

Researchers are conducting a study of how human blood cells work. Their goal is to examine how these cells respond to different bacteria and other foreign substances.

physician and patient smiling

The UNISUS study will compare the effectiveness and safety of a higher dose of an investigational medication called Opsumit to a lower dose in people with pulmonary arterial hypertension (PAH). The results of the UNISUS Study will provide more information about the investigational medication’s effectiveness and safety when it is given as a higher dose to adults with PAH.

baby hands on adult hands

Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.

A growing number of people with cystic fibrosis (CF) are considering parenthood. CF specialists recognize that there is a need to better support first-time parents and need input from them.

Doctor listening to mans heart

Researchers are examining whether an investigational medication called buloxibutid can slow down lung scarring and improve breathing for people with idiopathic pulmonary fibrosis (IPF). Volunteers are needed. Learn if you are eligible for the ASPIRE IPF trial

Researchers in this clinical trial want to determine if a new investigational treatment called NS-229 can help people with EGPA experience remission of their symptoms or reduce the need for oral steroids.